Madrigal Pharmaceuticals, Inc. MDGL
NASDAQ · United States · Health Technology
$503.96-5.48 (-1.08%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-07-30 | -1.99 | -2.68 | +25.7% | $364.30M | +3.5% | -14.5%$546.88→$467.32 |
| Q1 2026 | 2026-05-06 | -1.38 | -4.14 | +66.7% | — | — | +6.4%$502.47→$534.86 |
| Q4 2025 | 2026-02-19 | -2.57 | -0.88 | -192.0% | — | — | -11.5%$491.49→$435.01 |
| Q3 2025 | 2025-11-04 | -4.96 | -1.99 | -149.2% | — | — | +15.4%$412.35→$475.87 |
| Q2 2025 | 2025-08-05 | -1.90 | -3.53 | +46.2% | — | — | — |
| Q1 2025 | 2025-05-01 | -3.32 | -3.79 | +12.4% | — | — | — |
| Q4 2024 | 2025-02-26 | -2.71 | -4.12 | +34.2% | — | — | — |
| Q3 2024 | 2024-10-31 | -4.92 | -6.91 | +28.8% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.